Angiotensin blockade therapy and survival in pancreatic cancer: A population study
Angiotensin blockade therapy and survival in pancreatic cancer: A population study
Pancreatic cancer (PC) is one of the most aggressive and challenging cancer types to effectively treat, ranking as the fourth-leading cause of cancer death in the United States. We investigated if exposures to angiotensin II receptor blockers (ARBs) or angiotensin I converting enzyme (ACE) inhibitors after PC diagnosis are associated with survival.